Health
‘Baricitinib’: This arthritis drug may improve Covid survival in elderlies – ummid.com
This is one of the first Covid-19 treatments to go from computer to clinic and laboratory, study authors said
London: Scientists have claimed that a type of arthritis drug called ‘baricitinib’ may reduce the risk of dying among elderly patients infected with Covid-19.
This medication is usually used to treat rheumatoid arthritis, and was initially identified by the Imperial College London using artificial intelligence as a drug that could have anti-viral and anti-inflammatory effects.
In the early-stage study, 83 patients, with a median age of 81 and all suffering from moderate to severe COVID-19 infection,…
-
Noosa News21 hours agoSuncorp Stadium upgrades to rival Sydney as seat capacity and infrastructure prioritised
-
General14 hours agoAustralia Kangaroos lose Xavier Coates and Zac Lomax ahead of rugby league Ashes in England
-
Business23 hours agoDroneShield announces new $13 million counter-drone facility as employees top 400
-
Noosa News21 hours ago‘The Book of Mormon’ Returns to Melbourne and Brisbane in 2026